Logo image of MS

MORGAN STANLEY (MS) Stock Fundamental Analysis

NYSE:MS - New York Stock Exchange, Inc. - US6174464486 - Common Stock - Currency: USD

124.1  -2.16 (-1.71%)

Fundamental Rating

3

MS gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 230 industry peers in the Capital Markets industry. MS has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, MS is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year MS was profitable.
In the past year MS had a positive cash flow from operations.
In the past 5 years MS has always been profitable.
In multiple years MS reported negative operating cash flow during the last 5 years.
MS Yearly Net Income VS EBIT VS OCF VS FCFMS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B -20B 40B

1.2 Ratios

MS's Return On Assets of 1.05% is on the low side compared to the rest of the industry. MS is outperformed by 64.78% of its industry peers.
Looking at the Return On Equity, with a value of 12.25%, MS is in the better half of the industry, outperforming 66.96% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 1.34%, MS is doing worse than 67.83% of the companies in the same industry.
MS had an Average Return On Invested Capital over the past 3 years of 1.17%. This is significantly below the industry average of 7.27%.
The last Return On Invested Capital (1.34%) for MS is above the 3 year average (1.17%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 1.05%
ROE 12.25%
ROIC 1.34%
ROA(3y)0.89%
ROA(5y)0.97%
ROE(3y)10.46%
ROE(5y)11.1%
ROIC(3y)1.17%
ROIC(5y)1.28%
MS Yearly ROA, ROE, ROICMS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

MS has a Profit Margin of 11.93%. This is comparable to the rest of the industry: MS outperforms 43.91% of its industry peers.
MS's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 16.40%, MS is not doing good in the industry: 63.48% of the companies in the same industry are doing better.
In the last couple of years the Operating Margin of MS has declined.
MS's Gross Margin of 53.71% is fine compared to the rest of the industry. MS outperforms 61.74% of its industry peers.
In the last couple of years the Gross Margin of MS has declined.
Industry RankSector Rank
OM 16.4%
PM (TTM) 11.93%
GM 53.71%
OM growth 3Y-20.12%
OM growth 5Y-4.82%
PM growth 3Y-20.6%
PM growth 5Y-5.48%
GM growth 3Y-16.51%
GM growth 5Y-5.78%
MS Yearly Profit, Operating, Gross MarginsMS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

0

2. Health

2.1 Basic Checks

The number of shares outstanding for MS has been reduced compared to 1 year ago.
Compared to 5 years ago, MS has more shares outstanding
The debt/assets ratio for MS is higher compared to a year ago.
MS Yearly Shares OutstandingMS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
MS Yearly Total Debt VS Total AssetsMS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200B 400B 600B 800B 1T

2.2 Solvency

MS has an Altman-Z score of -0.08. This is a bad value and indicates that MS is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of MS (-0.08) is worse than 76.52% of its industry peers.
MS has a Debt/Equity ratio of 6.99. This is a high value indicating a heavy dependency on external financing.
MS has a worse Debt to Equity ratio (6.99) than 86.09% of its industry peers.
Industry RankSector Rank
Debt/Equity 6.99
Debt/FCF N/A
Altman-Z -0.08
ROIC/WACCN/A
WACCN/A
MS Yearly LT Debt VS Equity VS FCFMS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100B 200B

2.3 Liquidity

MS has a Current Ratio of 0.30. This is a bad value and indicates that MS is not financially healthy enough and could expect problems in meeting its short term obligations.
MS has a Current ratio of 0.30. This is amonst the worse of the industry: MS underperforms 80.00% of its industry peers.
A Quick Ratio of 0.30 indicates that MS may have some problems paying its short term obligations.
MS has a Quick ratio of 0.30. This is amonst the worse of the industry: MS underperforms 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.3
Quick Ratio 0.3
MS Yearly Current Assets VS Current LiabilitesMS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200B 400B 600B

5

3. Growth

3.1 Past

MS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 51.33%, which is quite impressive.
The Earnings Per Share has been growing by 8.88% on average over the past years. This is quite good.
Looking at the last year, MS shows a quite strong growth in Revenue. The Revenue has grown by 10.79% in the last year.
MS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.79% yearly.
EPS 1Y (TTM)51.33%
EPS 3Y-0.38%
EPS 5Y8.88%
EPS Q2Q%28.71%
Revenue 1Y (TTM)10.79%
Revenue growth 3Y20.63%
Revenue growth 5Y14.79%
Sales Q2Q%17.2%

3.2 Future

Based on estimates for the next years, MS will show a small growth in Earnings Per Share. The EPS will grow by 6.26% on average per year.
Based on estimates for the next years, MS will show a small growth in Revenue. The Revenue will grow by 3.10% on average per year.
EPS Next Y12.41%
EPS Next 2Y9.97%
EPS Next 3Y10.25%
EPS Next 5Y6.26%
Revenue Next Year9.06%
Revenue Next 2Y6.52%
Revenue Next 3Y5.46%
Revenue Next 5Y3.1%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MS Yearly Revenue VS EstimatesMS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 20B 40B 60B 80B 100B
MS Yearly EPS VS EstimatesMS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5 10 15 20

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 14.57, the valuation of MS can be described as correct.
MS's Price/Earnings is on the same level as the industry average.
MS's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 25.91.
The Price/Forward Earnings ratio is 12.92, which indicates a correct valuation of MS.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MS is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of MS to the average of the S&P500 Index (21.85), we can say MS is valued slightly cheaper.
Industry RankSector Rank
PE 14.57
Fwd PE 12.92
MS Price Earnings VS Forward Price EarningsMS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

MS's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. MS is cheaper than 76.09% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 17.93
MS Per share dataMS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.17
PEG (5Y)1.64
EPS Next 2Y9.97%
EPS Next 3Y10.25%

5

5. Dividend

5.1 Amount

MS has a Yearly Dividend Yield of 2.79%.
MS's Dividend Yield is comparable with the industry average which is at 8.11.
Compared to an average S&P500 Dividend Yield of 2.36, MS has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.79%

5.2 History

The dividend of MS is nicely growing with an annual growth rate of 18.94%!
MS has been paying a dividend for at least 10 years, so it has a reliable track record.
MS has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)18.94%
Div Incr Years10
Div Non Decr Years13
MS Yearly Dividends per shareMS Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

47.95% of the earnings are spent on dividend by MS. This is a bit on the high side, but may be sustainable.
The dividend of MS is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP47.95%
EPS Next 2Y9.97%
EPS Next 3Y10.25%
MS Yearly Income VS Free CF VS DividendMS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B -20B
MS Dividend Payout.MS Dividend Payout, showing the Payout Ratio.MS Dividend Payout.PayoutRetained Earnings

MORGAN STANLEY

NYSE:MS (5/23/2025, 9:40:10 AM)

124.1

-2.16 (-1.71%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)04-11 2025-04-11/bmo
Earnings (Next)07-16 2025-07-16/bmo
Inst Owners62.19%
Inst Owner Change0.61%
Ins Owners0.19%
Ins Owner Change-0.03%
Market Cap199.43B
Analysts72.9
Price Target128.84 (3.82%)
Short Float %1.21%
Short Ratio1.75
Dividend
Industry RankSector Rank
Dividend Yield 2.79%
Yearly Dividend3.8
Dividend Growth(5Y)18.94%
DP47.95%
Div Incr Years10
Div Non Decr Years13
Ex-Date04-30 2025-04-30 (0.925)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)21.16%
Min EPS beat(2)15.26%
Max EPS beat(2)27.07%
EPS beat(4)4
Avg EPS beat(4)16.98%
Min EPS beat(4)7.49%
Max EPS beat(4)27.07%
EPS beat(8)7
Avg EPS beat(8)9.28%
EPS beat(12)9
Avg EPS beat(12)6.46%
EPS beat(16)13
Avg EPS beat(16)7.97%
Revenue beat(2)2
Avg Revenue beat(2)4.23%
Min Revenue beat(2)3.68%
Max Revenue beat(2)4.78%
Revenue beat(4)4
Avg Revenue beat(4)3.09%
Min Revenue beat(4)1.95%
Max Revenue beat(4)4.78%
Revenue beat(8)5
Avg Revenue beat(8)8.56%
Revenue beat(12)9
Avg Revenue beat(12)12.37%
Revenue beat(16)12
Avg Revenue beat(16)10.47%
PT rev (1m)-8.76%
PT rev (3m)-6.65%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4.2%
EPS NY rev (1m)0.25%
EPS NY rev (3m)-0.51%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.78%
Revenue NY rev (1m)0.85%
Revenue NY rev (3m)-0.82%
Valuation
Industry RankSector Rank
PE 14.57
Fwd PE 12.92
P/S 1.86
P/FCF N/A
P/OCF 146.42
P/B 1.91
P/tB 2.45
EV/EBITDA 17.93
EPS(TTM)8.52
EY6.87%
EPS(NY)9.6
Fwd EY7.74%
FCF(TTM)-1.31
FCFYN/A
OCF(TTM)0.85
OCFY0.68%
SpS66.76
BVpS65.03
TBVpS50.62
PEG (NY)1.17
PEG (5Y)1.64
Profitability
Industry RankSector Rank
ROA 1.05%
ROE 12.25%
ROCE 3.05%
ROIC 1.34%
ROICexc 1.5%
ROICexgc 1.58%
OM 16.4%
PM (TTM) 11.93%
GM 53.71%
FCFM N/A
ROA(3y)0.89%
ROA(5y)0.97%
ROE(3y)10.46%
ROE(5y)11.1%
ROIC(3y)1.17%
ROIC(5y)1.28%
ROICexc(3y)1.31%
ROICexc(5y)1.45%
ROICexgc(3y)1.39%
ROICexgc(5y)1.52%
ROCE(3y)2.71%
ROCE(5y)2.94%
ROICexcg growth 3Y-6.85%
ROICexcg growth 5Y1.53%
ROICexc growth 3Y-6.8%
ROICexc growth 5Y1.26%
OM growth 3Y-20.12%
OM growth 5Y-4.82%
PM growth 3Y-20.6%
PM growth 5Y-5.48%
GM growth 3Y-16.51%
GM growth 5Y-5.78%
F-Score7
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 6.99
Debt/FCF N/A
Debt/EBITDA 32.08
Cap/Depr 67.08%
Cap/Sales 3.23%
Interest Coverage 0.38
Cash Conversion 5.98%
Profit Quality N/A
Current Ratio 0.3
Quick Ratio 0.3
Altman-Z -0.08
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)74.75%
Cap/Depr(5y)63.46%
Cap/Sales(3y)3.81%
Cap/Sales(5y)3.59%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)51.33%
EPS 3Y-0.38%
EPS 5Y8.88%
EPS Q2Q%28.71%
EPS Next Y12.41%
EPS Next 2Y9.97%
EPS Next 3Y10.25%
EPS Next 5Y6.26%
Revenue 1Y (TTM)10.79%
Revenue growth 3Y20.63%
Revenue growth 5Y14.79%
Sales Q2Q%17.2%
Revenue Next Year9.06%
Revenue Next 2Y6.52%
Revenue Next 3Y5.46%
Revenue Next 5Y3.1%
EBIT growth 1Y41.98%
EBIT growth 3Y-3.64%
EBIT growth 5Y9.26%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y94.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y104.06%
OCF growth 3Y-65.77%
OCF growth 5Y-49.33%